Extended duration safety and efficacy of adjunctive ganaxolone treatment in patients with CDKL5 deficiency disorder: 8-month minimum open-label extension follow-up H. Olson,A. Moosa, E. Rybak, A. Aimetti,J. Hulihan, E. Pestana-KnightEPILEPSIA（2022）引用 1|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
